Policy1h ago
Regulators Hold Closed-Door Clinical AI Meetings
Federal health officials invited tech lobbyists and companies to private meetings to accelerate AI adoption in healthcare. These sessions aim to streamline how clinical AI tools enter medical practice. The lack of transparency regarding these discussions raises questions about influence. Practitioners should watch for new regulatory shortcuts that favor specific industry players over open standards.